VTAK · CIK 0001716621 · operating
Catheter Precision, Inc. operates in the cardiac electrophysiology medical device sector, designing and manufacturing technologies used in the diagnosis and treatment of heart rhythm disorders. The company's flagship product is the View into Ventricular Onset System, a non-invasive 3D cardiac mapping platform that localizes the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts. This imaging system is intended for use prior to electrophysiology procedures to help clinicians identify target areas. The company also manufactures LockeT, a suture retention device that temporarily secures sutures and assists clinicians in locating and removing them during cardiac procedures.
Catheter Precision is headquartered in Fort Mill, South Carolina, and maintains a small operational footprint with 22 full-time employees. The company focuses on the United States market. Its product portfolio targets cardiac electrophysiologists and hospitals performing arrhythmia ablation and management procedures.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | — | $-6.68 | — | |
| 2023 | — | — | — | |
| 2022 | $-25.98 | $-25.98 | — | |
| 2021 | — | — | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — | |
| 2018 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2024-12-31 | 2025-03-31 | 0001437749-25-009918 | SEC ↗ |
| 2023-12-31 | 2024-04-01 | 0001654954-24-003964 | SEC ↗ |
| 2022-12-31 | 2023-03-28 | 0001564590-23-004567 | SEC ↗ |
| 2021-12-31 | 2022-03-24 | 0001564590-22-011555 | SEC ↗ |
| 2020-12-31 | 2021-03-17 | 0001564590-21-013653 | SEC ↗ |
| 2019-12-31 | 2020-03-11 | 0001564590-20-010123 | SEC ↗ |
| 2018-12-31 | 2019-03-15 | 0001564590-19-007905 | SEC ↗ |